Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,303,788
- Total 13F value
- $3,542,705
- Share change
- +48,161
- SEC-reported price per share
- $1.08
- Number of holders
- 43
- Value change
- +$51,253
- Number of buys
- 8
- Number of sells
- 11
- Shares outstanding
- 11,676,558
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2025
Institutions
43
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Ownership snapshot
Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Clearline Capital LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
30 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 5.5%
13D/G row: Clearline Capital LP
Showing 1-6 of 15 holder rows.
Quick read
Clearline Capital LP leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Clearline Capital LP
5.5%
Rubric Capital Management LP
10%
VANGUARD GROUP INC
3.2%
Tejara Capital Ltd
2.9%
ADAR1 Capital Management, LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Clearline Capital LP |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$736,858
635,222 shares
|
— | 30 Jun 2025 |
| Rubric Capital Management LP |
3/4/5
13F
Director, Other*, 10%+ Owner · Company
|
10%
from 13F
|
$6,718,950
2,946,908 shares
|
— | 15 Nov 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.2%
|
$439,641
379,001 shares
|
— | 30 Jun 2025 |
| Tejara Capital Ltd |
13F
Company
|
2.9%
|
$399,335
344,254 shares
|
— | 30 Jun 2025 |
| ADAR1 Capital Management, LLC |
13F
Company
|
1.8%
|
$242,684
209,210 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
1.1%
|
$152,203
131,210 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
3,303,788
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
39
Q3 2025 holders
43
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend